Fed. Cir.

Pfizer Inc. v. Teva Pharmaceuticals USA, No. 12-1576 (Fed. Cir. Feb. 6, 2014)

Infringement Claim Construction Enablement Written Description

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 12-1576
Decided: February 6, 2014
Judge: Prost, J.
Document: Nonprecedential Opinion
Length: 21 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Eliza- beth, LLC; Cobalt Laboratories, Inc. ; Cobalt Pharmaceu- ticals, Inc.; Sun Pharma Global, Inc.; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; Wockhardt USA, LLC ; Alphapharm Pty. Ltd.; and Mylan Pharmaceuticals, Inc.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error